Showing results (401-410 of 411) with videos related to
Sort By:
Pageof 42
Pediatrics|November 17, 2023
Race, Ethnicity, and Ancestry in Clinical Pathways: A Framework for EvaluationRobert H Rosen, Alexandra Epee-Bounya, Dorothy Curran, et al.The Journal of Pharmacology and Experimental Therapeutics|January 30, 2004
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypesM Forrest, S-Y Sun, R Hajdu, et al.Psychosomatics|July 16, 2020
Updates in Consultation-Liaison Psychiatry: 2019Scott A Simpson, Lydia A Chwastiak, Sarah R Andrews, et al.JCI Insight|April 22, 2024
In utero and postnatal ivacaftor/lumacaftor therapy rescues multiorgan disease in CFTR-F508del ferretsIdil Apak Evans, Xingshen Sun, Bo Liang, et al.Science (New York, N.Y.)|January 29, 1999
Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibioticH Rosen, R Hajdu, L Silver, et al.JCI Insight|February 1, 2022
Ferret models of alpha-1 antitrypsin deficiency develop lung and liver diseaseNan He, Xiaoming Liu, Amber R Vegter, et al.Science Translational Medicine|March 29, 2019
In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosisXingshen Sun, Yaling Yi, Ziying Yan, et al.American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout FerretsBradley H Rosen, T Idil Apak Evans, Shashanna R Moll, et al.JCI Insight|April 19, 2019
A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucusCourtney M Fernandez-Petty, Gareth W Hughes, Hannah L Bowers, et al.Nature|September 21, 2023
Transgenic ferret models define pulmonary ionocyte diversity and functionFeng Yuan, Grace N Gasser, Evan Lemire, et al.Pageof 42